EndoCross Ltd.

Industry · 1 registered clinical trial.

Status	Trial	Phase	Started
Withdrawn	Accessing Peripheral Occluded LesiOns II (APOLO-II) Femoropopliteal Occlusive Disease	Phase 3	2013-06-01